Ethris GmbH, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics and vaccines, and the German Center for Infection Research (DZIF), today announced a strategic research
INCATE (INCubator for Antibacterial Therapies in Europe), the antimicrobial incubator supporting the advancement of early stage anti-infectives, announced a defining milestone in its institutional
Professor Oliver T. Keppler, Chair of Virology at the Max von Pettenkofer Institute at Ludwig Maximilian University (LMU) in Munich, passed away on January 27, 2026 following a serious illness. As an
Phyton Biotech has successfully transferred the manufacturing process for the microbial production of Corallopyronin A (CorA). CorA is a novel anti-infective agent with the potential to address
Urinary tract infections are among the most common reasons for prescribing antibiotics. Since conventional pathogen identification in the laboratory usually takes two to three days, initial treatment
Most malaria drugs are combination therapies based on artemisinin, an active ingredient derived from the medicinal plant Artemisia annua (sweet wormwood). The malaria parasite Plasmodium falciparum is
The World Neglected Tropical Diseases (NTD) Day on January 30 aims to raise awareness of diseases that affect millions of people worldwide but are usually overshadowed by other global health issues
A new study has shown for the first time that an experimental vaccine against Middle East Respiratory Syndrome (MERS) induces a stable and functional immune response in humans that persists for at
The Parliamentary Group on Antimicrobial Resistance (PKAMR) convened on January 13, 2026, for its second working session of this legislative period in the German Bundestag. The focus was on how to
On February 23 and 24, 2026, experts from the German Center for Infection Research (DZIF) and the Paul-Ehrlich-Society for Infection Therapy (PEG) will meet at the Maritim Hotel in Bonn for their
